Description
Zhejiang Kinglyuan Pharmaceutical Company Limited is an integrated enterprise founded in 1998, specialising in the development and manufacturing of pharmaceutical products. The company is renowned for its focus on antihypertensive agents, particularly a series of sartan products, including Telmisartan, Candesartan Cilexetil, Valsartan, and Irbesartan. It stands as the largest manufacturer of Telmisartan, Cilostazol, and their intermediates within China, solidifying its position as a key supplier in the pharmaceutical industry.
Services include:
– Intermediates
– Fine Chemicals
– Research and Development
– Custom Synthesis
– Contract Manufacturing
Zhejiang Kinglyuan Pharmaceutical Co Ltd remains committed to delivering high-quality products and services tailored to the needs of the pharmaceutical sector. For further information, please visit kinglyuan.com.
Capabilities
Contact Information
Related Listings

CDMO Live Americas . October 20-21, Boston 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st Oct 2026

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl










